Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)

PHASE4CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2009

Conditions
Disorders of Gallbladder, Biliary Tract and Pancreas
Interventions
DRUG

propofol

For induction, 25 mg of meperidine and 2.5 mg of midazolam were administered in both groups. In the cocktail group, one milligram per kilogram body weight of 1% propofol emulsion (Baxter Healthcare Corp., Irvine, CA) was slowly infused by an automated pump (Terufusion syringe pump TE-331, Terumo Corporation, Tokyo, Japan). To maintain conscious level of patient in the conventional group to be at moderate or deep level, 25 mg of meperidine and/or 2.5 mg of midazolam were administered as necessary, whereas patients in the cocktail group were continuously administered with 1% propofol at the rate of 1 mg/kg/hr. An additional 0.5 mg/kg bolus was administered as needed to achieve the designed conscious level.

Trial Locations (1)

10330

Gastroenterology Unit, King Chulalongkorn Memorial Hospital, Patumwan

All Listed Sponsors
lead

King Chulalongkorn Memorial Hospital

OTHER

NCT01540084 - Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP) | Biotech Hunter | Biotech Hunter